These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1418779)

  • 1. Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis.
    Pachon J; Cisneros JM; Castillo JR; Garcia-Pesquera F; Cañas E; Viciana P
    AIDS; 1992 Aug; 6(8):827-30. PubMed ID: 1418779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.
    Barry M; Howe JL; Back DJ; Swart AM; Breckenridge AM; Weller IV; Beeching N; Nye F
    Br J Clin Pharmacol; 1994 Jan; 37(1):7-12. PubMed ID: 8148221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
    Moore KH; Raasch RH; Brouwer KL; Opheim K; Cheeseman SH; Eyster E; Lemon SM; van der Horst CM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2732-7. PubMed ID: 8593010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic study of zidovudine in parenteral drug addicts with human immunodeficiency virus infection].
    Pachón J; Viciana P; Cisneros JM; García Pesquera F; Castillo JR; Cañas E
    Med Clin (Barc); 1993 Jan; 100(2):46-9. PubMed ID: 8429708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of single and chronic dose zidovudine in two HIV positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Gallicano KD; Tobe S; Sahai J; McGilveray IJ; Cameron DW; Kriger F; Garber G
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):242-50. PubMed ID: 1740749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions.
    Burger DM; Meenhorst PL; ten Napel CH; Mulder JW; Neef C; Koks CH; Bult A; Beijnen JH
    AIDS; 1994 Dec; 8(12):1683-9. PubMed ID: 7888117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of 3'-azido-3 deoxy-thymidine (AZT) in a patient undergoing hemodialysis].
    Deray G; Diquet B; Martinez F; Vidal AM; Petitclerc T; Land G; Raymond F; Baumelou A; Jacobs C
    Therapie; 1989; 44(6):405-8. PubMed ID: 2623654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
    Gibb D; Barry M; Ormesher S; Nokes L; Seefried M; Giaquinto C; Back D
    Br J Clin Pharmacol; 1995 May; 39(5):527-30. PubMed ID: 7669489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of zidovudine in HIV-positive patients with liver disease.
    Bareggi SR; Cinque P; Mazzei M; D'Arminio A; Ruggieri A; Pirola R; Nicolin A; Lazzarin A
    J Clin Pharmacol; 1994 Jul; 34(7):782-6. PubMed ID: 7929874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.
    Morse GD; Portmore AC; Marder V; Plank C; Olson J; Taylor C; Bonnez W; Reichman RC
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.
    Meng TC; Fischl MA; Cheeseman SH; Spector SA; Resnick L; Boota A; Petrakis T; Wright B; Richman DD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):152-60. PubMed ID: 7834398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.
    Stretcher BN; Pesce AJ; Frame PT; Greenberg KA; Stein DS
    AIDS; 1994 Jun; 8(6):763-9. PubMed ID: 8086134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of zidovudine in HIV-infected patients with end-stage renal disease.
    Kimmel PL; Lew SQ; Umana WO; Li PP; Gordon AM; Straw J
    Blood Purif; 1995; 13(6):340-6. PubMed ID: 8821198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of high-dose zidovudine administered as a continuous infusion in patients with cancer.
    Marchbanks K; Dudley MN; Posner MR; Darnowski J
    Pharmacotherapy; 1995; 15(4):451-7. PubMed ID: 7479197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).
    McCance-Katz EF; Rainey PM; Jatlow P; Friedland G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):435-43. PubMed ID: 9715839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.
    Schwartz EL; Brechbühl AB; Kahl P; Miller MA; Selwyn PA; Friedland GH
    J Acquir Immune Defic Syndr (1988); 1992; 5(6):619-26. PubMed ID: 1588496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of zidovudine (AZT) and its metabolite (G-AZT) in healthy subjects and in patients with kidney failure].
    Pioger JC; Taburet AM; Colin JN; Colaneri S; Fillastre JP; Singlas E
    Therapie; 1989; 44(6):401-4. PubMed ID: 2623653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?
    Fauchet F; Treluyer JM; Valade E; Benaboud S; Pannier E; Firtion G; Foissac F; Bouazza N; Urien S; Hirt D
    Br J Clin Pharmacol; 2014 Dec; 78(6):1387-96. PubMed ID: 25040510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children.
    Fauchet F; Treluyer JM; Frange P; Urien S; Foissac F; Bouazza N; Benaboud S; Blanche S; Hirt D
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4801-8. PubMed ID: 23877688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.